Inverse Blood Pressure Rhythm of Transgenic Hypertensive TGR(mREN2)27 Rats: Role of Norepinephrine and Expression of Tyrosine‐Hydroxylase and Reuptake₁‐Transporter

References

• Ackermann H. BIAS–Biometrische Analyse von Stichproben. Epsilon‐Verlag, Hochheim‐Darmstadt 1997
   Google Scholar
• Böhm M., Castellano M., Flesch M., Maack C., Moll M., Paul M., Schiffer F., Zolk O. Chamber‐specific alterations of norepinephrine uptake sites in cardiac hypertrophy. Hypertension 1998; 32: 831–837
   PubMed Web of Science ®Google Scholar
• Brasch H., Sieroslawski L., Dominiak P. Angiotensin ll increases norepinephrine release form atria by acting on angiotensin suptype 1 receptors. Hypertension 1993; 22: 699–704
   PubMed Web of Science ®Google Scholar
• Chevillard C., Barden N., Saavedra J. M. Twenty‐four hour rhythm in monoamine oxidase activity in specific areas of the rat brain stem. Brain Res. 1983; 223: 205–209
   Web of Science ®Google Scholar
• Feldberg W., Lewis G. P. The action of peptides on the adrenal medulla. Releases of adrenalin by bradykinin and angiotensin. J. Physiol. 1964; 171: 98–108
   PubMed Web of Science ®Google Scholar
• Ferrario M. C. Neurogenic actions of angiotensin ll. Hypertension 1983; 5(Suppl V)V73–V79
   PubMedGoogle Scholar
• Gelband C. H., Sumners C., Lu D., Raizada M. K. Angiotensin receptors and norepinephrine neuromodulation: implications of functional coupling. Regul. Pept. 1998; 73: 141–147
   PubMedGoogle Scholar
• Kaschina E., Unger T. Angiotensin AT1/2 receptors: regulation, signalling and function. Blood Press. 2003; 12: 70–88
   PubMed Web of Science ®Google Scholar
• Khairallah P. A. Action of angiotensin on adrenergic nerve endings: inhibition of norepinephrine uptake. Fed. Proc. 1972; 31: 1351–1357
   PubMedGoogle Scholar
• Kline R. L., Chow K. Z., Mercer P. F. Does enhanced sympathetic tone contribute to angiotensin hypertension in rats. Eur. J. Pharmacol. 1990; 184: 109–118
   PubMed Web of Science ®Google Scholar
• Lemmer B., Saller R. Influence of light and darkness on the turnover of noradrenaline in the rat heart. Naunyn‐Schmiedeberg's Arch. Pharmacol. 1974; 282: 75–84
   Google Scholar
• Lemmer B., Wenda K. Diurnal rhythms in the noradrenaline turnover and motility after reserpine and 6‐hydroxydopamine. Pharmac. Biochem. Behav. 1979; 10: 361–368
   PubMed Web of Science ®Google Scholar
• Lemmer B., Portaluppi F. Chronopharmacology of cardiovascular diseases. Handbook of Experimental Pharmacology: Physiology and Pharmacology of Biological Rhythms, P. Redfern, B. Lemmer. Springer, New York 1997; 125: 251–297
   Google Scholar
• Lemmer B., Mattes A., Böhm M., Ganten D. Circadian blood pressure variation in transgenic hypertensive rats. Hypertension 1993; 22: 97–101
   PubMed Web of Science ®Google Scholar
• Lemmer B., Witte K., Schänzer A., Findeisen A. Circadian rhythms in the renin‐angiotensin‐system and adrenal steroids may contribute to the inverse blood pressure rhythm in hypertensive TGR(mREN‐2)27 rats. Chronobiol. Int. 2000; 17: 645–658
   PubMed Web of Science ®Google Scholar
• Lemmer B., Rueff T., Reiter S., Huser L., Hauptfleisch S., Witte K. Influence of circadian time and age on glomerular angiotensin II receptors in normotensive Sprague‐Dawley and transgenic hypertensive TGR(mREN2)27 rats. Chronobiol. Int. 2001; 18: 447–459
   PubMed Web of Science ®Google Scholar
• Lemmer B., Witte K., Enzminger H., Schiffer S., Hauptfleisch S. Transgenic TGR(mREN2)27 rats as a model for disturbed circadian organisation at the level of the brain, the heart, and the kidneys. Chronobiol. Int. 2003; 20: 711–738
   PubMed Web of Science ®Google Scholar
• Lu D., Yu K., Paddy M. R., Rowland N. E., Raizada M. K. Regulation of norepinephrine transport system by angiotensin II in neuronal cultures of normotensive and spontaneously hypertensive rat brains. Endocrinology 1996; 137: 763–772
   PubMed Web of Science ®Google Scholar
• Mullins J. J., Peters J., Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse ren‐2 gen. Nature 1990; 344: 541–544
   PubMed Web of Science ®Google Scholar
• Nickenig G., Laufs U., Schnabel P., Knorr A., Paul M., Böhm M. Down‐regulation of aortic and cardiac AT1‐receptor gene expression in transgenic (mRen‐2)27 rats. Brit. J. Pharmacol. 1997; 121: 134–140
   PubMed Web of Science ®Google Scholar
• Pons M., Schnecko A., Witte K., Lemmer B., Waterhouse J. M., Cambar J. Circadian rhythms in renal functions in hypertensive TGR(mRen2)27 rats and their normotensive controls. Am. J. Physiol. Reg. Integrat. Comp. Physiol. 1996; 40: R1002–R1008
   Google Scholar
• Schiffer S., Pummer S., Witte K., Lemmer B. Cardiovascular regulation in TGR(mREN2)27 rats: 24h variation in plasma catecholamines, angiotensin peptides and in telemetric heart rate variability. Chronobiol. Int. 2000; 18: 461–474
   Web of Science ®Google Scholar
• Spät A., Hunyady L. Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol. Rev. 2004; 84: 489–539
   PubMed Web of Science ®Google Scholar
• Tokita Y., Franco‐Saenz R., Mulrow P. J., Ganten D. Effects of nephrectomy and adreanlectomy on the renin‐angiotensin system of transgenic rats TGR(mRen2)27. Endocrinology 1994; 134: 253–257
   PubMed Web of Science ®Google Scholar
• Touitou Y., Portaluppi F., Smolensky M. H., Rensing L. Ethical principles and standards for the conduct of human and animal biological rhythm research. Chronobiol. Int. 2004; 21: 161–170
   PubMed Web of Science ®Google Scholar
• Witte K., Lemmer B. Development of inverse circadian blood pressure pattern in transgenic hypertensive TGR(mREN2)27 rats. Chronobiol. Int. 1999; 16: 293–303
   PubMed Web of Science ®Google Scholar
• Witte K., Huser L., Knotter B., Heckmann M., Schiffer S., Lemmer B. Normalisation of blood pressure in hypertensive TGR(mREN2)27 rats by amlodipine vs. enalapril: effects on cardiac hypertrophy and signal transduction pathways. Naunyn‐Schmiedeberg's Arch. Pharmacol. 2001; 363: 101–109
   Google Scholar
• Witte K., Schnecko A., Buijs R. M., Vliet J., van der, Scalbert E., Delagrange Ph., Guardiola‐Lemaître B., Lemmer B. Effects of SCN‐lesions on circadian blood pressure rhythm in normotensive and transgenic hypertensive rats. Chronobiol. Int. 1998; 15: 135–145
   PubMed Web of Science ®Google Scholar
• Yu K., Lu D., Rowland N. E., Raizada M. K. Angiotensin II regulation of tyrosine hydroxylase gene expression in the neuronal cultures of normotensive and spontaneously hypertensive rats. Endocrinology 1996; 137: 3566–3576
   PubMed Web of Science ®Google Scholar
• Zhao Y., Bader M., Kreutz R., Fernandez‐Alfonso, Zimmermann F., Ganten U., Metzger R., Ganten D., Mullins J. J., Peters J. Ontogenetic regulation of mouse Ren‐2d renin gene in transgenic hypertensive rats, TGR(mREN2)27. Am. J. Physiol. 1993; 265: E699–E707
   PubMed Web of Science ®Google Scholar
• Zimmerman B. G. Actions of angiotensin on adrenergic nerve endings. Fed. Proc. 1978; 37: 199–202
   PubMedGoogle Scholar